Medications that help manage spastic cerebral palsy primarily focus on reducing muscle spasticity, improving mobility, and enhancing quality of life by targeting the neurological pathways responsible for muscle overactivity. The most commonly used medications include oral baclofen, benzodiazepines, botulinum toxin injections, phenol injections, and intrathecal baclofen delivered via a pump.
**Baclofen** is a cornerstone medication for spasticity management. It is a gamma-aminobutyric acid (GABA-B) receptor agonist that works by inhibiting excitatory neurotransmission in the spinal cord, thereby reducing muscle tone and spasms. Oral baclofen is typically started at a low dose (around 5 mg three times daily) and gradually increased as tolerated, with a maximum dose often cited around 80 mg/day, though some patients may require doses up to 300 mg/day under careful supervision. However, oral baclofen can cause systemic side effects such as sedation and weakness, limiting its use in some patients[1][2].
For more severe or generalized spasticity, **intrathecal baclofen therapy** is an effective option. This involves surgically implanting a pump that delivers baclofen directly into the cerebrospinal fluid around the spinal cord, allowing higher local concentrations with fewer systemic effects. Typical dosing ranges from 90 to 1,000 micrograms per day depending on the origin and severity of spasticity. Intrathecal baclofen can significantly reduce whole-body spasticity, improve ease of care, sitting, positioning, and sometimes mobility. However, it requires surgery, ongoing pump refills, and monitoring for complications such as infection or pump malfunction[1][2][6].
**Botulinum toxin injections** (e.g., Botox) are widely used for focal spasticity, especially when spasticity affects specific muscle groups interfering with therapy, brace use, or daily activities. Botulinum toxin works by blocking acetylcholine release at the neuromuscular junction, causing temporary muscle paralysis and relaxation. The effects typically last several months, allowing improved function and ease of care. Botulinum toxin injections are minimally invasive, reversible, and can be repeated as needed. They are often combined with physical therapy for optimal results. Procedural sedation techniques, including nitrous oxide and topical anesthetics, are used to minimize discomfort during injections in children[2][3][5].
**Phenol injections** are another option for focal spasticity, particularly in more severe cases or when longer-lasting relief is desired. Phenol causes neurolysis (nerve destruction) of motor nerves, leading to a reduction in muscle overactivity that can last from 6 to 12 months. Like botulinum toxin, phenol injections are minimally invasive and repeatable but tend to provide longer-lasting effects. They are useful for improving positioning, reducing severe spasticity, and facilitating daily caregiving[2].
**Benzodiazepines** such as diazepam may also be used as adjunctive therapy for spasticity due to their muscle relaxant and sedative properties. However, their use is often limited by sedation and tolerance development[1].
In clinical practice, the choice of medication depends on the severity and distribution of spasticity, patient age, response to previous treatments, and side effect profiles. Oral medications are often first-line for mild to moderate spasticity, while focal treatments like botulinum toxin or phenol injections are preferred for localized spasticity. Intrathecal baclofen is reserved for severe, generalized spasticity unresponsive to other treatments.
Beyond medications, comprehensive spasticity management includes physical therapy, occupational therapy, orthotic devices, and sometimes surgical interventions, all tailored to the individual’s needs[7].
**References:**
[1] EMCrit Project, Baclofe
